AC Immune SA (ACIU)
2.97
-0.06
(-1.98%)
USD |
NASDAQ |
Sep 22, 16:00
2.99
+0.02
(+0.67%)
After-Hours: 20:00
AC Immune Price: 2.97 for Sept. 22, 2023
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Sep 22, 2023 | 2.99 | 3.04 | 2.94 | 2.97 | 25791.00 |
Sep 21, 2023 | 3.06 | 3.08 | 2.92 | 3.03 | 36556.00 |
Sep 20, 2023 | 3.01 | 3.17 | 2.99 | 3.08 | 35646.00 |
Sep 19, 2023 | 3.05 | 3.13 | 2.95 | 3.01 | 35665.00 |
Sep 18, 2023 | 3.08 | 3.084 | 2.92 | 3.01 | 89952.00 |
Sep 15, 2023 | 3.16 | 3.19 | 3.005 | 3.02 | 149566.0 |
Sep 14, 2023 | 3.25 | 3.30 | 3.16 | 3.17 | 25443.00 |
Sep 13, 2023 | 3.35 | 3.35 | 3.17 | 3.24 | 38853.00 |
Sep 12, 2023 | 3.33 | 3.36 | 3.23 | 3.36 | 33284.00 |
Sep 11, 2023 | 3.34 | 3.44 | 3.27 | 3.33 | 49528.00 |
Sep 08, 2023 | 3.24 | 3.30 | 3.16 | 3.29 | 29998.00 |
Sep 07, 2023 | 3.17 | 3.32 | 3.10 | 3.16 | 62216.00 |
Sep 06, 2023 | 3.20 | 3.29 | 3.16 | 3.19 | 64813.00 |
Sep 05, 2023 | 3.41 | 3.45 | 3.22 | 3.30 | 95667.00 |
Sep 01, 2023 | 3.27 | 3.386 | 3.26 | 3.38 | 64982.00 |
Aug 31, 2023 | 3.22 | 3.30 | 3.190 | 3.25 | 41751.00 |
Aug 30, 2023 | 3.25 | 3.25 | 3.10 | 3.21 | 56764.00 |
Aug 29, 2023 | 3.18 | 3.37 | 3.07 | 3.11 | 111203.0 |
Aug 28, 2023 | 3.06 | 3.28 | 3.06 | 3.16 | 66515.00 |
Aug 25, 2023 | 3.11 | 3.16 | 3.06 | 3.06 | 39783.00 |
Aug 24, 2023 | 3.13 | 3.150 | 3.060 | 3.10 | 21942.00 |
Aug 23, 2023 | 3.06 | 3.15 | 3.03 | 3.12 | 61630.00 |
Aug 22, 2023 | 3.10 | 3.18 | 3.03 | 3.06 | 49188.00 |
Aug 21, 2023 | 3.04 | 3.120 | 3.00 | 3.08 | 53817.00 |
Aug 18, 2023 | 2.98 | 3.07 | 2.96 | 3.05 | 24731.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.72
Minimum
Dec 22 2022
11.70
Maximum
Dec 13 2018
5.441
Average
5.20
Median
Aug 28 2019
Price Benchmarks
CRISPR Therapeutics AG | 45.49 |
Addex Therapeutics Ltd | 0.3657 |
NLS Pharmaceutics Ltd | 0.77 |
Molecular Partners AG | 4.70 |
MoonLake Immunotherapeutics | 52.19 |
Price Related Metrics
Price to Book Value | 1.601 |
Earnings Yield | -28.75% |
Market Cap | 248.09M |